Jonathan Marron MD

Jonathan M. Marron, MD

Associate in Ethics; Clinical Ethicist

Instructor in Pediatrics, Harvard Medical School

    Contact: 617-632-3453
  • Fax: 617-632-4410

Medical Services


  • Hematologic Malignancy
  • Solid Tumors
  • Clinical Genomics
  • Medical Ethics


  • Hematology / Oncology


  • Hematologic Malignancies
  • Solid Tumor Program
To schedule an appointment: Call 617-632-3453

Experience and Education


Medical School

David Geffen School of Medicine at UCLA, 2008

Los Angeles, CA

Internship, Pediatrics

Lucile Packard Children’s Hospital at Stanford University, 2009

Palo Alto, CA

Residency, Pediatrics

Lucile Packard Children’s Hospital at Stanford University, 2011

Palo Alto, CA

Fellowship, Clinical Ethics

MacLean Center for Clinical Medical Ethics, University of Chicago, 2012

Chicago, IL

Fellowship, Health Services Research

Harvard Medical School, 2016

Boston, MA


  • American Board of Pediatrics

Professional History

Dr. Marron received his medical degree from the David Geffen School of Medicine at UCLA in 2008. He completed his residency in Pediatrics at Stanford University and his fellowship in Clinical Medical Ethics at the University of Chicago followed by his fellowship in Pediatric Hematology/Oncology at Boston Children’s Hospital and the Dana-Farber Cancer Institute. Dr. Marron is an attending physician at the Jimmy Fund Clinic and at Boston Children’s Hospital. He is also currently a fellow in the Harvard-Wide Pediatric Health Research Fellowship and an MPH candidate at the Harvard T.H. Chan School of Public Health. His research interests are in ethics and decision-making, health services, clinical genomics, informed consent, and medical uncertainty.


Publications powered by Harvard Catalyst Profiles
  1. Marron JM, Jones E, Wolfe J. Is There Ever a Role for the Unilateral Do Not Attempt Resuscitation Order in Pediatric Care? J Pain Symptom Manage. 2017 Sep 12.
  2. Marron JM, Joffe S. Ethical considerations in genomic testing for hematologic disorders. Blood. 2017 Jul 27; 130(4):460-465.
  3. Cohen B, Roth M, Marron JM, Gray SW, Geller DS, Hoang B, Gorlick R, Janeway KA, Gill J. Pediatric Oncology Provider Views on Performing a Biopsy of Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling. Ann Surg Oncol. 2016 Dec; 23(Suppl 5):990-997.
  4. Marron JM, DuBois SG, Glade Bender J, Kim A, Crompton BD, Meyer SC, Janeway KA, Mack JW. Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience. Pediatr Blood Cancer. 2016 Nov; 63(11):1974-82.
  5. Marron JM, Truog RD. Against "Healthy Paternalism" at the End of Life. JAMA Oncol. 2016 Jun 01; 2(6):832.
  6. Venkatramani R, Pan H, Furman WL, Marron JM, Haduong J, Friedrich-Medina P, Mahajan A, Bavle A, Wu H, Chintagumpala M. Multimodality Treatment of Pediatric Esthesioneuroblastoma. Pediatr Blood Cancer. 2016 Mar; 63(3):465-70.
  7. Marron JM, Mack JW. When to say when: How aggressively to care for children with multiply relapsed cancer? Pediatr Blood Cancer. 2015 Jul; 62(7):1119-20.
  8. Marron J. Physician attitudes toward industry: room for improvement. Arch Surg. 2010 Dec; 145(12):1213.
  9. Marron JM, Siegler M. Ethical issues in innovative colorectal surgery. Dis Colon Rectum. 2005 Jun; 48(6):1109-13.
To schedule an appointment: Call 617-632-3453


Boston Children’s is so much more than a hospital—it’s a community of researchers, clinicians, administrators, support staff, innovators, teachers, patients and families, all working together to make the impossible possible. ”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337